Multidrug-resistant tuberculosis that required 2 years for diagnosis.
Shuichi Yano, Kanako Kobayashi, Toshikazu Ikeda
Index: BMJ Case Rep. 2012 , doi:10.1136/bcr.02.2010.2775, (2012)
Full Text: HTML
Abstract
Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.
Related Compounds
Related Articles:
2015-02-09
[ChemBioChem. 16(3) , 424-31, (2015)]
2015-12-03
[Nature 528 , 127-31, (2015)]
2015-01-01
[J. Pharm. Biomed. Anal. 102 , 9-16, (2014)]
2014-12-01
[Invest. Ophthalmol. Vis. Sci. 55(12) , 8111-22, (2014)]
2015-06-01
[J. Enzyme Inhib. Med. Chem. 30 , 420-9, (2015)]